Sponsor:
Barbara Ann Karmanos Cancer Institute
Code:
NCT07735819
Conditions
Low Grade Glioma
Glioblastoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Minocycline 200mg/day
[18F]FETrp PET/CT
Brief summary:
Conditions
Low Grade Glioma
Glioblastoma
Study ID
NCT07735819
Start date
Nov, 2026
Status verified date
Nov, 2026
Completion date
Jun 30, 2031
Anticipated
Primary completion date
Jun 30, 2031
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
61 participants
Anticipated
Allocation
Non randomized
Intervention Model
Parallel Assignment
Primary purpose
Diagnostic
Arms
experimental: [18F]FETrp PET/CT in newly diagnosed grade 4 glioma prior to radiation
experimental: [18F]FETrp PET/CT in previously treated gliomas with post radiation progression
experimental: [18F]FETrp PET/CT pre and post Minocycline 200mg/day
Interventions
Minocycline 200mg/day
[18F]FETrp PET/CT
Primary outcome measure
Central contacts
Locations
Karmanos Cancer Institute
Recruiting
Detroit, Michigan, United States, 48201
Contacts
Csaba Juhasz, M.D., Ph.D
1-800-527-6266Sponsor
Barbara Ann Karmanos Cancer Institute
Last update posted
Nov 18, 2026
Last verified
Nov, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-19. This information was provided to ClinicalTrials.gov by Barbara Ann Karmanos Cancer Institute on 2026-11-18. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.